NCT06104371 Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
| NCT ID | NCT06104371 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vastra Gotaland Region |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 459 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 459 participants in total. It began in 2025-09-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Magnetic tracer injected before preoperative chemotherapy in breast cancer patients for sentinel lymph node detection. Also, magnetic tracer in combination with magnetic clip for index node identification.
Eligibility Criteria
Inclusion criteria: * Patients 18 years of age or older. * Patients with breast cancer planned to undergo NACT with * planned sentinel lymph node dissection (SLND), or * targeted axillary lymph node dissection (TAD), in conjunction with the * breast surgery after NACT. Exclusion Criteria: * Intolerance / hypersensitivity to iron or dextran compounds or SPIO. * Patients who are required to undergo MRI to evaluate tumour response. * Pregnancy or breast feedin.g * Patients with an iron overload disease. * Patient deprived of liberty or under guardianship. * Inability to understand given information and give informed consent or undergo study procedure
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06104371 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06104371 currently recruiting?
Yes, NCT06104371 is actively recruiting participants. Contact the research team at fredrik.warnberg@vgregion.se for enrollment information.
Where is the NCT06104371 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT06104371 clinical trial?
NCT06104371 is sponsored by Vastra Gotaland Region. The trial plans to enroll 459 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.